James N Topper, a major owner of Nivalis Therapeutics, Inc. and a director of the company, just received 7,650 options from the company. The strike price of the options received was $11.31, and these expire on January 01, 2028. Topper now owns at least 7,650 options on the company.
Some additional info was provided as follows:
The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
100% of the shares subject to the option become vested and exercisable on January 2, 2019.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Nivalis Therapeutics, Inc. makes a similar move, sign up!